HIV associated nephropathy laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}{{APM}};{{AE}}{{KW}} {{SHA}}
{{CMG}}{{APM}};{{AE}}{{KW}} {{SHA}}
==Overview==
==Overview==
Laboratory findings in HIV-associated nephropathy include: high-grade proteinuria, elevated serum creatinine levels, hypoalbuniemia, hyperlipidemia, CD4 counts below 200 cells/mm<sup>3</sup>, hyaline casts, leukocytes, oval fat bodies, and microhematuria.
Laboratory findings in HIV-associated nephropathy include: proteinuria, elevated serum creatinine levels, decreased GFR, dyslipidemia, CD4 counts below 200 cells/mm<sup>3</sup> , and hematuria.


==Laboratory Findings==
==Laboratory Findings==
Line 25: Line 25:
* Hematuria
* Hematuria


Routine laboratory tests that may be ordered to help in identify HIV-associated nephropathy (HIVAN) are:
Routine laboratory tests that may be ordered to help in identify HIV-associated nephropathy (HIVAN) may include:


'''Blood Work-up'''
'''Blood Work-up'''

Revision as of 07:22, 29 June 2020

HIV associated nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating HIV associated nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

KUB X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV associated nephropathy laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV associated nephropathy laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV associated nephropathy laboratory findings

CDC on HIV associated nephropathy laboratory findings

HIV associated nephropathy laboratory findings in the news

Blogs on HIV associated nephropathy laboratory findings

Directions to Hospitals Treating HIV associated nephropathy

Risk calculators and risk factors for HIV associated nephropathy laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3] Shakiba Hassanzadeh, MD[4]

Overview

Laboratory findings in HIV-associated nephropathy include: proteinuria, elevated serum creatinine levels, decreased GFR, dyslipidemia, CD4 counts below 200 cells/mm3 , and hematuria.

Laboratory Findings

Renal Biopsy

  • Renal biopsy is the standard in establishing a diagnosis of HIV-associated nephropathy.
  • Renal biopsy reveals focal segmental glomerulonephritis, significant tubulointerstitial injury and microcystic tubular dilation are characteristically seen. [1]
  • Renal biopsy is an essential tool for evaluation and identification of HIV-associated and other kidney diseases in HIV-positive patients, which is important in the management and treatment of the patients.[2]

Other Laboratory Findings

HIV-associated nephropathy (HIVAN) can not be diagnosed clinically or with noninvasive measures such as laboratory findings or ultrasound.[3][4][5]

Laboratory findings in HIV-associated nephropathy include:[6][7]

  • Proteinuria
  • Elevated serum creatinine levels
  • Decreased GFR
  • Dyslipidemia
  • CD4 counts below 200 cells/mm3
  • Hematuria

Routine laboratory tests that may be ordered to help in identify HIV-associated nephropathy (HIVAN) may include:

Blood Work-up

  • Complete blood count (CBC)
  • Serum creatinine
  • Lipid profile
  • Albumin
  • ELISA
  • Dot blot
  • Latex agglutination test
  • Hepatitis B
  • Hepatitis C

Supplemental Test

  • Western blot
  • Immunofluorescence

Urinalysis

  • Proteinuria
  • Microhematuria
  • Leukocytes
  • Oval fat bodies
  • Hyaline casts


References

  1. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G (1989). "Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study". Kidney Int. 35 (6): 1358–70. PMID 2770114.
  2. Fine DM, Perazella MA, Lucas GM, Atta MG (2008). "Kidney biopsy in HIV: beyond HIV-associated nephropathy". Am J Kidney Dis. 51 (3): 504–14. doi:10.1053/j.ajkd.2007.12.005. PMID 18295067.
  3. Atta MG, Lucas GM, Fine DM (2008). "HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management". Expert Rev Anti Infect Ther. 6 (3): 365–71. doi:10.1586/14787210.6.3.365. PMID 18588500.
  4. Atta MG, Choi MJ, Longenecker JC, Haymart M, Wu J, Nagajothi N; et al. (2005). "Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy". Am J Med. 118 (11): 1288. doi:10.1016/j.amjmed.2005.05.027. PMID 16271919.
  5. Atta MG, Longenecker JC, Fine DM, Nagajothi N, Grover DS, Wu J; et al. (2004). "Sonography as a predictor of human immunodeficiency virus-associated nephropathy". J Ultrasound Med. 23 (5): 603–10, quiz 612-3. doi:10.7863/jum.2004.23.5.603. PMID 15154526.
  6. Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM; et al. (2012). "HIV-associated kidney glomerular diseases: changes with time and HAART". Nephrol Dial Transplant. 27 (6): 2349–55. doi:10.1093/ndt/gfr676. PMID 22248510.
  7. Bigé N, Lanternier F, Viard JP, Kamgang P, Daugas E, Elie C; et al. (2012). "Presentation of HIV-associated nephropathy and outcome in HAART-treated patients". Nephrol Dial Transplant. 27 (3): 1114–21. doi:10.1093/ndt/gfr376. PMID 21745806.

Template:WH Template:WS